dalteparin has been researched along with Infections, Prosthesis-Related in 3 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rivaroxaban has been recommended for routine use as a thromboprophylactic agent in patients undergoing lower-limb arthroplasty." | 1.37 | Return to theatre following total hip and knee replacement, before and after the introduction of rivaroxaban: a retrospective cohort study. ( Jensen, CD; Muller, SD; Partington, PF; Reed, MR; Steval, A, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gomila-Sard, B | 1 |
| Téllez-Castillo, CJ | 1 |
| Sabater-Vidal, S | 1 |
| Moreno-Muñoz, R | 1 |
| Muñoz Morente, A | 1 |
| Barón Ramos, MA | 1 |
| Mateos Fernández, S | 1 |
| López Palmero, S | 1 |
| Villar Jiménez, J | 1 |
| Regueira Iglesias, JM | 1 |
| Jensen, CD | 1 |
| Steval, A | 1 |
| Partington, PF | 1 |
| Reed, MR | 1 |
| Muller, SD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Blood Saving Effect and Wound-related Complications of Tranexamic Acid in Mininally Invasive Total Knee Arthroplasty With Rivaroxaban as Thromboprophylaxis[NCT02458729] | Phase 4 | 294 participants (Actual) | Interventional | 2012-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for dalteparin and Infections, Prosthesis-Related
| Article | Year |
|---|---|
[Early prosthetic joint infection due to Streptococcus oralis].
Topics: Aged; Antibiotic Prophylaxis; Anticoagulants; Arthritis, Infectious; Arthroplasty, Replacement, Knee | 2009 |
[Anticoagulation with bemiparina after intracerebral hemorrhage as complication of bacterial endocarditis on metallic prosthetic valve].
Topics: Cerebral Hemorrhage; Endocarditis, Bacterial; Heart Valve Prosthesis; Heparin, Low-Molecular-Weight; | 2004 |
Return to theatre following total hip and knee replacement, before and after the introduction of rivaroxaban: a retrospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Fem | 2011 |